Canadian Government, Sanofi To Build C$925M Flu Vaccine Facility In Toronto

  • Sanofi SA SNY is dropping a major investment into its supply chain by shelling C$925 million to build a new manufacturing facility in Toronto.
  • The new facility will be operational by 2026 and provide additional antigen and filling capacity for Fluzone, a high-dose flu vaccine.
  • In partnership with the Governments of Canada, Ontario, and the City of Toronto, the new facility will enhance influenza pandemic preparedness efforts and vaccine manufacturing capacity.
  • The federal government will invest C$415 million in the project, and the provincial government C$55 million. Sanofi has also promised at least $79 million a year to fund research and development.
  • Sanofi will invest more than C$455 million and create 165 new jobs in Canada and maintain another 1,100 others.
  • The facility will help increase the supply of Fluzone in Canada, the U.S., and Europe.
  • Price Action: SNY shares are up 0.51% at $49.36 in market trading hours on the last check Wednesday.
Loading...
Loading...
SNY Logo
SNYSanofi SA
$48.320.29%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
33.06
Growth
99.55
Quality
21.28
Value
54.52
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...